July 27, 2017, Canton, MA – Draper Therapies is thrilled to announce that the United States Food and Drug Administration has determined that products containing Celliant® meet the criteria for medical devices and general wellness products and will be categorized as such. All of Draper Therapies’ products contain Celliant, a smart fiber clinically proven to:
Increase Energy – this energy penetrates into the muscle and tissue to promote a temporary increase in
local blood flow
Recycled human energy
Promote restful sleep
Help increase comfort and promotes restful sleep
“Our customers and anyone who has used Celliant knows that it works, but this just lends credence to our experience,” says Draper Therapies product manager Becky Shipps. “I think that FDA determination is incredibly important because it will encourage folks to try our products and generate interest in responsive textiles in general. I am excited for the future of both Draper Therapies and Celliant!”
To shop the Draper Therapies product line, click here.
To read more about Celliant, click here.